Table 2.
Disease modeling approach using brain organoids.
Disease model | Type of organoid | Phenotypes | Cell | References |
---|---|---|---|---|
Neurodevelopmental disease | ||||
Microcephaly | Forebrain organoid | • Reduction in overall size of organoid • Premature differentiation of NPCs |
hiPSCs | Lancaster et al., 2013 |
Microcephaly (caused by ZIKA virus) | NPCs, Neurosphere brain organoid | • Reduction in overall size of organoid • Cell disruption and death in neurospheres |
hiPSCs | Garcez et al., 2016 |
Forebrain organoid | • Preferentially infection in NPCs at the early stage organoid • Reduction in overall size and VZ layer thickness |
hiPSCs | Qian et al., 2016 | |
NPCs brain organoid | • Premature differentiation of NPCs • Reduction in VZ and cortical layer • Defect in centrosomal structure of NPCs |
hiPSCs | Gabriel et al., 2017 | |
Cerebral organoid | • Activation of Toll-like receptor 3 (TLR3) after ZIKA infection • Dysregulation of neurogenesis genes • Reduction in overall size and neuroepithelium |
hESCs | Dang et al., 2016 | |
Lissencephaly (Miller-Dieker syndrome) | Cerebral organoid | • Reduction in overall size of organoid • Increased apoptosis of NESCs • Decreased migration of neurons • Mitotic delay in oRGCs |
hiPSCs | Bershteyn et al., 2017 |
Forebrain organoid | • Reduction in overall size of organoid • Division plane of vRGCs was changed from symmetric to asymmetric • Altered microtubule network organization of vRGCs |
hiPSCs | Iefremova et al., 2017 | |
Rett syndrome (RTT) | Cerebral organoid | • Increased number of proliferating NPCs • Expanded VZ area • Impaired neurogenesis and maturation |
hiPSCs | Mellios et al., 2018 |
Neuropsychiatric disease | ||||
Schizophrenia | Cerebral organoid | • Increased NPC proliferation • Abnormal premature migration of NPCs • Malformation in cortical region |
hiPSCs | Stachowiak et al., 2017 |
Neurodegenerative disease | ||||
Alzheimer's disease (AD) | hNPCs embedded in matrigel | • Amyloid-β deposition • Hyperphosphorylation of tau protein • Attenuated symptoms by β- or γ-secretase inhibitor treatment |
hNPCs | Choi et al., 2014 |
Scaffold-free 3D brain organoid model | • Amyloid-β deposition and hyperphosphorylation of tau protein occurred sequentially over time • Attenuated symptoms by β- or γ-secretase inhibitor treatment |
hiPSCs | Raja et al., 2016 | |
Cerebral organoid | • Amyloid-β deposition • Hyperphosphorylation of tau protein • Similar phenotypes of Down syndrome(DS) brain organoid |
hiPSCs | Gonzalez et al., 2018 | |
Parkinson's disease (PD) | Midbrain organoid (Sporadic PD model with LRRK2-muatation) | • Decreased DA neuron and mature neuron • Abnormal localization of α-synuclein • Suggesting a relationship between TXNIP gene and sporadic PD |
hiPSCs | Kim et al., 2019 |